Technical CommentsCancer
Response to Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia”
- Damian Lai1,2,
- Min Chen1,
- Jiechuang Su1,3,
- Xiaohu Liu1,2,
- Katharina Rothe1,3,
- Kaiji Hu1,
- Donna L. Forrest2,4,
- Connie J. Eaves1,2,3,
- Gregg B. Morin3,5 and
- Xiaoyan Jiang1,2,3,*
- 1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
- 2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
- 3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
- 4Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC V5Z 1M9, Canada.
- 5Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
- ↵*Corresponding author. Email: xjiang{at}bccrc.ca
See allHide authors and affiliations
Science Translational Medicine 17 Jul 2019:
Vol. 11, Issue 501, eaav0819
DOI: 10.1126/scitranslmed.aav0819
Vol. 11, Issue 501, eaav0819
DOI: 10.1126/scitranslmed.aav0819
Damian Lai
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Min Chen
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Jiechuang Su
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Xiaohu Liu
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Katharina Rothe
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Kaiji Hu
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Donna L. Forrest
Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Connie J. Eaves
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Gregg B. Morin
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Xiaoyan Jiang
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
